These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6133613)
1. Changes in extrapyramidal symptoms following anticholinergic drug withdrawal. Perenyi A; Gardos G; Samu I; Kallos M; Cole JO Clin Neuropharmacol; 1983 Mar; 6(1):55-61. PubMed ID: 6133613 [TBL] [Abstract][Full Text] [Related]
2. A depot neuroleptic withdrawal study neurological effects. Wistedt B; Wiles D; Jørgensen A Psychopharmacology (Berl); 1983; 80(2):101-5. PubMed ID: 6136059 [TBL] [Abstract][Full Text] [Related]
3. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs. Luchins DJ; Freed WJ; Wyatt RJ Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078 [TBL] [Abstract][Full Text] [Related]
4. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients. Carter G Br J Psychiatry; 1983 Feb; 142():166-8. PubMed ID: 6132644 [TBL] [Abstract][Full Text] [Related]
5. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Mori K; Yamashita H; Nagao M; Horiguchi J; Yamawaki S Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapy. Lavin MR; Rifkin A J Clin Pharmacol; 1991 Aug; 31(8):769-77. PubMed ID: 1679063 [TBL] [Abstract][Full Text] [Related]
7. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs. Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760 [TBL] [Abstract][Full Text] [Related]
8. Adverse effects of antiparkinson drug withdrawal. Jellinek T; Gardos G; Cole JO Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of maintenance use of anticholinergic agents. Double DB; Warren GC; Evans M; Rowlands RP Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226 [TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia and anticholinergic drugs. Gardos G; Cole JO Am J Psychiatry; 1983 Feb; 140(2):200-2. PubMed ID: 6129809 [TBL] [Abstract][Full Text] [Related]
11. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone. Nishimura K; Tsuka M; Horikawa N Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome after neuroleptic discontinuation. Amore M; Zazzeri N Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212 [TBL] [Abstract][Full Text] [Related]
14. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. Tran PV; Dellva MA; Tollefson GD; Beasley CM; Potvin JH; Kiesler GM J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614 [TBL] [Abstract][Full Text] [Related]
15. The rabbit syndrome and antiparkinsonian medication in schizophrenic patients. Wada Y; Yamaguchi N Neuropsychobiology; 1992; 25(3):149-52. PubMed ID: 1357583 [TBL] [Abstract][Full Text] [Related]
16. Insomnia related to biperiden withdrawal in two schizophrenic patients. Hirose S Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012 [TBL] [Abstract][Full Text] [Related]
17. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Bezchlibnyk-Butler KZ; Remington GJ Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605 [TBL] [Abstract][Full Text] [Related]
18. Abuse and misuse of anticholinergic medications. Land W; Pinsky D; Salzman C Hosp Community Psychiatry; 1991 Jun; 42(6):580-1. PubMed ID: 1677920 [No Abstract] [Full Text] [Related]